APA

Miyashita T., Enosawa S., Suzuki S., Tamura A., Tanaka H., Amemiya H., Matsumura T., Omasa T., Suga K., Aoki T. & Koyanagi Y. (20010802). Development of a bioartificial liver with glutamine synthetase-transduced recombinant human hepatoblastoma cell line, HepG2. : Transplantation proceedings.

Chicago

Miyashita T, Enosawa S, Suzuki S, Tamura A, Tanaka H, Amemiya H, Matsumura T, Omasa T, Suga K, Aoki T and Koyanagi Y. 20010802. Development of a bioartificial liver with glutamine synthetase-transduced recombinant human hepatoblastoma cell line, HepG2. : Transplantation proceedings.

Harvard

Miyashita T., Enosawa S., Suzuki S., Tamura A., Tanaka H., Amemiya H., Matsumura T., Omasa T., Suga K., Aoki T. and Koyanagi Y. (20010802). Development of a bioartificial liver with glutamine synthetase-transduced recombinant human hepatoblastoma cell line, HepG2. : Transplantation proceedings.

MLA

Miyashita T, Enosawa S, Suzuki S, Tamura A, Tanaka H, Amemiya H, Matsumura T, Omasa T, Suga K, Aoki T and Koyanagi Y. Development of a bioartificial liver with glutamine synthetase-transduced recombinant human hepatoblastoma cell line, HepG2. : Transplantation proceedings. 20010802.